SGLT2 Inhibitors and Pulmonary Arterial Hypertension: A Retrospective Study

被引:0
|
作者
Abu-Rmaileh, M. [1 ]
Abu-Rmaileh, M. [1 ]
Hardin, E. [2 ]
Shah, T. [1 ]
Chin, K. M. [3 ]
机构
[1] UTSW, Internal Med, Dallas, TX USA
[2] UTSW, Cardiol, Dallas, TX USA
[3] UT SouthWestern, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6119
引用
收藏
页数:2
相关论文
共 50 条
  • [21] SGLT2 inhibitors: are they safe?
    Filippas-Ntekouan, Sebastian
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
  • [22] SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
    Gupta, Rahul
    Maitz, Theresa
    Egeler, David
    Mehta, Anila
    Nyaeme, Mark
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Patel, Neel
    Aronow, Wilbert S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 479 - 486
  • [23] SGLT2 INHIBITORS IN KIDNEY TRANSPLANTATION: A MULTICENTER STUDY
    Garcia Carro, Clara
    Bedia Raba, Andrea
    Banegas Deras, Eduardo J.
    Alberto Vigara, Luis
    Valero San Cecilio, Rosalia
    Cruzado Vega, Leonidas
    Gavela, Eva
    Gonzalez Garcia, M. Elena
    Perez-Flores, Isabel
    Sanchez-Bielsa, Francisco
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I884 - I884
  • [24] Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Across the Spectrum of Hypertension
    Sanidas, Elias A.
    Papadopoulos, Dimitrios P.
    Hatziagelaki, Erifili
    Grassos, Charalampos
    Velliou, Maria
    Barbetseas, John
    AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (03) : 207 - 213
  • [25] The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension
    Chowdhury, B.
    Luu, V. Z.
    Luu, A. Z.
    Kabir, M. G.
    Pan, Y.
    Teoh, H.
    Quan, A.
    Mazer, C. D.
    Verma, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 11 - 11
  • [26] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
  • [27] Development of SGLT1 and SGLT2 inhibitors
    Rieg, Timo
    Vallon, Volker
    DIABETOLOGIA, 2018, 61 (10) : 2079 - 2086
  • [28] RENAL OUTCOMES OF SGLT2 INHIBITORS IN PATIENTS WITH DIABETES IN THE UNITED STATES: RETROSPECTIVE COHORT STUDY
    Abegaz, T.
    Ahmed, M. B.
    Ali, A. A.
    VALUE IN HEALTH, 2023, 26 (06) : S42 - S42
  • [29] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [30] SGLT2 inhibitors in diabetes with CKD
    Malik, A. H.
    Yandrapalli, S.
    Goldberg, M.
    Jain, D.
    Frishman, W. H.
    Aronow, W. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448